Pyrene-Modified DNA Aptamers with High Affinity to Wild-Type EGFR and EGFRvIII

Elena Zavyalova1,2, Askar Turashev1, Anastasia Novoseltseva1,2

  • 1Apto-Pharm Ltd., Moscow, Russian Federation.

Nucleic Acid Therapeutics
|January 29, 2020
PubMed